Association between process indicators and in-hospital mortality among patients with chronic heart failure in China

European Journal of Public Health

Volumn 25, Issue 3, 2015, Pages 373-378

  Fu, Rong ^a   Xiang, Jing ^a   Bao, Han ^a   Wang, Zhiqiang ^b   Wang, Yupeng ^a   Chen, Yongjie ^a   Zhang, Huimin ^a   Liu, Dan ^a   Liu, Meina ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; CHINA; CHRONIC DISEASE; EPIDEMIOLOGY; FEMALE; HEALTH CARE QUALITY; HEART FAILURE; HOSPITAL MORTALITY; HUMAN; MALE; MIDDLE AGED; MORTALITY; STATISTICS AND NUMERICAL DATA;

AGED; CHINA; CHRONIC DISEASE; FEMALE; HEART FAILURE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; QUALITY INDICATORS, HEALTH CARE;

EID: 84939559934     PISSN: 11011262     EISSN: 1464360X     Source Type: Journal    
DOI: 10.1093/eurpub/cku187     Document Type: Article

References (38)

1. Gu DF, Huang GY, He J, et al. Investigation of prevalence and distributing feature of chronic heart failure in Chinese adult population. Chin J Cardiol 2003;31:3-6.
2. State Statistics Bureau. China Statistical Yearbook 2012. Beijing: Chinese Statistics Press, 2012.
3. Qian JF, Jiang H, Ge JB. The epidemiology and current therapy of chronic heart failure in China. Chin J Clin Med 2009;16:700-3.
4. Joint Commission on Accreditation of Healthcare Organizations. About The Joint Commission. Available at: http://www. jointcommission. org/about-us/about-the- joint-commission-main. Aspx (21 July 2013, date last accessed).
5. National Quality Forum. NQF Projects. Available at: http://www. qualityforum. org/ Projects. Aspx. (21 July 2013 date last accessed).
6. Canadian Cardiovascular Outcomes Research Team. CCORT Objectives. Available at: http://www. ccort. ca/CCORTBackground/CCORTObjectives. Aspx (21 July 21 2013, date last accessed).
7. Bonow RO, Bennett S, Casey DE, et al. ACC/AHA clinical performance measures for adults with chronic heart failure: A report of the American College of Cardiology/ American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures): endorsed by the Heart Failure Society of America. Circulation 2005;112:1853-87.
8. Fu R, Bao H, Zhang F, et al. Quality indicators for patients with chronic heart failure. Chin J Hosp Stat 2012;19:198-201.
9. Joint Commission on Accreditation of Healthcare Organizations. Core Measure Sets. Available at: http://www. jointcommission. org/assets/1/6/Heart%20Failure. pdf (4 May 4 2013, date last accessed).
10. Heidenreich PA, Fonarow GC. Quality indicators for the care of heart failure in vulnerable elders. J Am Geriatr Soc 2007;55:S340-6.
11. Lee DS, Tran C, Flintoft V, et al. CCORT/CCS quality indicators for congestive heart failure care. Can J Cardiol 2003;19:357-64.
12. Shahian DM, Meyer GS, Mort E, et al. Association of National Hospital Quality Measure adherence with long-term mortality and readmissions. BMJ Qual Saf 2012; 21:325-36.
13. Senni M, Rodeheffer RJ, Tribouilloy CM, et al. Use of echocardiography in the management of congestive heart failure in the community. J Am Coll Cardiol 1999; 33:164-70.
14. Luthi JC, McClellan WM, Fitzgerald D, et al. Mortality associated with the quality of care of patients hospitalized with congestive heart failure. Int J Qual Health Care 2002;14:15-24.
15. Luthi JC, Lund MJ, Sampietro-Colom L, et al. Readmissions and the quality of care in patients hospitalized with heart failure. Int J Qual Health Care 2003;15: 413-21.
16. Jha AK, Orav EJ, Li Z, et al. The inverse relationship between mortality rates and performance in the Hospital Quality Alliance measures. Health Aff 2007;26: 1104-10.
17. Hernandez AF, Hammill BG, Peterson ED, et al. Relationships between emerging measures of heart failure processes of care and clinical outcomes. Am Heart J 2010; 159:406-13.
18. Fonarow GC, Abraham WT, Albert NM, et al. Association between performance measures and clinical outcomes for patients hospitalized with heart failure. JAMA 2007;297:61-70.
19. Mansi IA, Shi R, Khan M, et al. Effect of compliance with quality performance measures for heart failure on clinical outcomes in high-risk patients. J Natl Med Assoc 2010;102:898-905.
20. Krumholz HM, Wang Y, Mattera JA, et al. An administrative claims model suitable for profiling hospital performance based on 30-day mortality rates among patients with an acute myocardial infarction. Circulation 2006;113:1683-92.
21. Shahian DM, Torchiana DF, Shemin RJ, et al. Massachusetts cardiac surgery report card: implications of statistical methodology. Ann Thorac Surg 2005;80:2106-113.
22. Lohr KN, Schroeder SA. A strategy for quality assurance in Medicare. N Engl J Med 1990;322:707-12.
23. Fonarow GC, Yancy CW, Heywood JT. Adherence to heart failure quality-of-care indicators in US hospitals: Analysis of the ADHERE Registry. Arch Intern Med 2005; 165:1469-77.
24. Luthi JC, McClellan WM, Fitzgerald D, et al. Variations among hospitals in the quality of care for heart failure. Eff Clin Pract 2000;3:69-77.
25. Havranek EP, Wolfe P, Masoudi FA, et al. Provider and hospital characteristics associated with geographic variation in the evaluation and management of elderly patients with heart failure. Arch Intern Med 2004;164:1186-91.
26. Luthi JC, McClellan WM, Flanders WD, et al. Variations in quality of care for heart failure. Swiss Med Wkly 2006;136:268-73.
27. The Chinese Society of Cardiology of the Chinese Medical Association. The editorial board of the Chinese Journal of Cardiology. The guidelines for diagnosis and treatment of patients with chronic heart failure. Chin J Cardiol 2007;35:1076-95.
28. Tribouilloy C, Rusinaru D, Mahjoub H, et al. Impact of echocardiography in patients hospitalized for heart failure: A prospective observational study. Arch Cardiovasc Dis 2008;101:465-73.
29. Pitt B, Williams G, Remme W, et al. The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Eplerenone Post-AMI Heart Failure Efficacy and Survival Study. Cardiovasc Drugs Ther 2001;15:79-87.
30. Flather MD, Yusuf S, Kober L, et al. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: A systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group. Lancet 2000;355:1575-81.
31. Granger CB, McMurray JJ, Yusuf S, et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: The CHARM-Alternative trial. Lancet 2003;362:772-6.
32. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999;341:709-17.
33. Faris R, Flather M, Purcell H, et al. Current evidence supporting the role of diuretics in heart failure: A meta analysis of randomised controlled trials. Int J Cardiol 2002; 82:149-58.
34. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial. Lancet 1999;353:9-13.
35. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001-7.
36. A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. N Engl J Med 2001;344:1659-67.
37. Packer M, Coats AJ, Fowler MB, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001;344:1651-8.
38. Fonarow GC. Improving quality of care and outcomes for heart failure. Role of registries. Circ J 2011;75:1783-90.